mixed results in raising money for her first love, environmental and ecological research. In 2000, she launched an interdisciplinary initiative on biocomplexity, which to date has received $334 million. But she was unable to implement a much larger move by the agency into environmental science proposed in 1998 (see Nature 395, 4; 1998).
Some were surprised at an outsider being appointed as the agency's interim leader. But Bement is seen as a safe pair of hands -he knows the NSF well, having served on its governing board for six years from 1989. ■ $219 million for a network of geological observatories.
The management of these projects was criticized in the Congress (see Nature 418, 573; 2002) and Colwell's insistence that all of them were progressing satisfactorily irritated some. "She drove them nuts from time to time,"says Joel Widder,a lobbyist and former senior NSF official who has worked for a congressional committee overseeing the agency. "She would continually insist that everything was on time and on budget." And Colwell, a marine biologist, had
The MRC, the secondlargest of the seven UK research councils, will provide fewer types of grants, but will offer more flexibility in their size and duration. Grants will vary from two to five years, and Blakemore hopes there will be a shortening of the application process from 26 to between 20 and 22 weeks.
Blakemore says that scientists and universities were consulted extensively in drawing up the reforms. "It was clear that simpler and more flexible schemes were needed," he says.
Large MRC projects, such as a planned genetic database called Biobank, won't be squeezed by the change, he adds. But some scientists say that they ought to be. "I am concerned about the way funding is skewed towards big projects," says Jim Cohen of the MRC Centre for Developmental Neurobiology at King's College, London. ■ Laura Nelson, London UK researchers are to get more cash and a simpler grant system, after a budget overhaul at the Medical Research Council (MRC).
The changes, which many researchers have been demanding for years, were announced on 13 February by Colin Blakemore, the MRC's chief executive. Blakemore, a neurobiologist, arrived to run the council from the University of Oxford last October.
In the financial year starting this April, the MRC will have £144 million (US$270 million) for competitive grant proposals, up from £124 million this year. And instead of having to apply in large, cooperative groups, investigators can go it alone.
Some researchers, and the House of Commons' science and technology committee, had criticized the old scheme, developed under Blakemore's predecessor George Radda (see Nature 422, 461; 2003) .
The new policy is a huge improvement, says David Price, a physiologist at the University of Edinburgh. The cooperative arrangement was "incredibly bureaucratic", he says. "Now we can think about the science we have in mind, rather than looking through the MRC schemes and modifying our science to suit them." Radda declined to comment on the change. Rita Colwell, the first woman to run the NSF, presided over a budget rise of two-thirds in six years. 
Medical research wins simpler grants and extra cash

